|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Department of Medicine, Division of Respirology, Critical Care, and Sleep Medicine, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, Canada.
Correspondence to: Donald W. Cockcroft, BSc, MD, FCCP, Royal University Hospital, Division of Respirology, Critical Care and Sleep Medicine, 103 Hospital Dr, Ellis Hall, Fifth Floor, Saskatoon, SK, S7N 0W8 Canada; e-mail: cockcroft{at}sask.usask.ca
Objective: To examine for tachyphylaxis to methacholine at 24 h and to use these data to assess the repeatability of the provocative concentration of a substance causing a 20% fall in FEV1 (PC20) for methacholine and to obtain statistical power calculations.
Design: Retrospective review of four double-blind, placebo-controlled studies with two methacholine PC20 values measured at 24-h intervals.
Setting: Tertiary university hospital bronchoprovocation laboratory.
Patients: Thirty-two subjects with mild-to-moderate well-controlled asthma.
Interventions: The placebo arms of the four studies were examined.
Measurements: Methacholine PC20 (using 2-min tidal breathing method) initial determination and repeat testing at 24 h.
Results: The geometric mean PC20 values were 1.57 mg/mL (95% confidence interval [CI], 1.0 to 2.4 mg/mL) and 1.62 mg/mL (95% CI, 1.0 to 2.6 mg/mL NSD; p = 0.64). The mean absolute difference between the two measurements was < 0.4 doubling concentrations, and 31 of 32 measurements had both values within one doubling concentration. These data provide a statistical power of 92% for 10 subjects to show a one-half concentration
PC20 and a mean power of 99 ± 1% to show a one-concentration
PC20.
Conclusions: There is no evidence for methacholine tachyphylaxis at 24 h in subjects with asthma. At 24 h, the average repeatability was well within a one-half concentration change, and individually 31 of 32 measurements (97%) were within one doubling concentration.
Key Words: methacholine power calculation repeatability tachyphylaxis tolerance
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |